Trial watch: peptide-based vaccines in anticancer therapy
Peptide-based anticancer vaccination aims at stimulating an immune response against one
or multiple tumor-associated antigens (TAAs) following immunization with purified …
or multiple tumor-associated antigens (TAAs) following immunization with purified …
[HTML][HTML] CpG oligodeoxynucleotides for anticancer monotherapy from preclinical stages to clinical trials
CpG oligodeoxynucleotides (CpG ODNs), the artificial versions of unmethylated CpG motifs
that were originally discovered in bacterial DNA, are demonstrated not only as potent …
that were originally discovered in bacterial DNA, are demonstrated not only as potent …
Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG
Y Gu, Y Liu, L Fu, L Zhai, J Zhu, Y Han, Y Jiang… - Nature medicine, 2019 - nature.com
Primary tumors may create the premetastatic niche in secondary organs for subsequent
metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles …
metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles …
[HTML][HTML] Anti-cancer auto-antibodies: Roles, applications and open issues
Simple Summary Cancer is one of the main causes of death worldwide and early detection
is crucial for effective treatment. Scientists have therefore focused on the identification of …
is crucial for effective treatment. Scientists have therefore focused on the identification of …
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma
W Peng, LJ Williams, C Xu, B Melendez… - Clinical Cancer …, 2019 - AACR
Purpose: OX40 agonist–based combinations are emerging as a novel avenue to improve
the effectiveness of cancer immunotherapy. To better guide its clinical development, we …
the effectiveness of cancer immunotherapy. To better guide its clinical development, we …
[HTML][HTML] Pharmacological activation of cGAS for cancer immunotherapy
KM Garland, JC Rosch, CS Carson… - Frontiers in …, 2021 - frontiersin.org
When compartmentally mislocalized within cells, nucleic acids can be exceptionally
immunostimulatory and can even trigger the immune-mediated elimination of cancer …
immunostimulatory and can even trigger the immune-mediated elimination of cancer …
Y-shaped oligonucleotides: a promising platform for enhanced therapy with siRNA and CpG Oligodeoxyribonucleotides
IS Yoon, HJ Nam, CA Hong - Biotechnology and Bioprocess Engineering, 2024 - Springer
Nucleic acids (DNA and RNA) have been recognized as promising building blocks to
fabricate a variety of well-defined two-and three-dimensional architectures through the …
fabricate a variety of well-defined two-and three-dimensional architectures through the …
Cytosine-phosphate-guanine oligodeoxynucleotides regulate the cell cycle, apoptosis, and steroidogenesis of mouse ovarian granulosa cells by targeting inhibin …
M Yang, J Feng, X Lan, Y Tang, Y Zhang… - In Vitro Cellular & …, 2022 - Springer
Cytosine-phosphate-guanine oligodeoxynucleotides (CpG-ODNs), which exist in vertebrate,
bacterial, and viral genomes, are regarded as strong immune adjuvants. To date, the …
bacterial, and viral genomes, are regarded as strong immune adjuvants. To date, the …
Engineering Innate Immune Activators for Intratumoral Immunotherapy
KM Garland - 2021 - ir.vanderbilt.edu
The development of cancer occurs when immunosuppression inhibits the naturally occurring
process through which the immune system recognizes and eliminates cancer cells (ie the …
process through which the immune system recognizes and eliminates cancer cells (ie the …
[PDF][PDF] Anti-cancer auto-antibodies: roles, applications and open issues. Cancers 2021, 13, 813
Auto-antibodies are classically associated with autoimmune diseases, where they are an
integral part of diagnostic panels. However, recent evidence is accumulating on the …
integral part of diagnostic panels. However, recent evidence is accumulating on the …